Indeks Harga Saham Gabungan (IHSG) Indonesia Stock ExchangeLet me know ur thought! I think there's bearish pattern on this IHSG chart, feel free to discuss!!
Stocks
S&P 500 Daily Chart Analysis For Week of Feb 14, 2025Technical Analysis and Outlook:
During the recent weekly trading session, the S&P 500 effectively reached and tested the critical Key Resistance level at 6083. It retested the completed Outer Index Rally at 6120, indicating a potential continuation of the bullish trend toward the intermediate target of 6233. However, a market pullback is anticipated due to this price action. Current analyses suggest that the designated downward target is set at the Mean Support level of 6049, with potential extensions to 5995, 5936, and the Outer Index Dip at 5878.
Microsoft - This Will Lead To Trouble!Microsoft ( NASDAQ:MSFT ) shows some clear weakness:
Click chart above to see the detailed analysis👆🏻
Back in mid 2024 Microsoft created another new all time high and in doing so also retested the major upper resistance trendline of the longer term rising channel formation. Following this bearish retest, a correction is very expected before we then see the bullish trend continuation.
Levels to watch: $350
Keep your long term vision,
Philip (BasicTrading)
MICROSOFT: Rectangle bottom buy opportunity.Microsoft is still bearish on its 1D technical outlook (RSI = 39.052, MACD = -6.600, ADX = 39.471) but that is to be expected as the price breached the 0.786 and almost touched the bottom of the 5 month Rectangle pattern. All breaks under the 0.786 have been strong buy opportunities targeting at least the 0.236 Fib. The trade is long (TP = 438.50).
## If you like our free content follow our profile to get more daily ideas. ##
## Comments and likes are greatly appreciated. ##
AMAZON BULLISH BIAS|LONG|
✅AMAZON is trading in an uptrend
With the stock set to retest
The rising support line
From where I think the growth will continue
LONG🚀
✅Like and subscribe to never miss a new idea!✅
SOFI Ready to Break Out to $30+ ?I’ve been watching this move closely, and right now, we’re heading toward $16.49—a level that could decide the next big move. If we break through $16.98, there’s a real shot at pushing toward $18.33 and beyond, with a longer-term target of $30+.
But here’s the flip side: if we reject at $16.49, we could see a pullback to $15.50, maybe even $14.50 if buyers don’t step in. That $1 range is where things could get really interesting.
I know a lot of you are in SOFI or watching it closely. What’s your plan? Are you holding, adding, or waiting for a dip?
Kris/ Mindbloome Exchange
Trade Smarter Live Better
CITIGROUP Gearing Up for a Bullish RallyNYSE:C is trading within a well-defined uptrend supported by a rising trendline. The consistent higher highs and higher lows confirm the bullish structure. If buyers maintain control and the price respects the trendline, the stock could rally toward the 87.14 target level, which aligns with a measured move projection.
For confirmation, I’ll look for bullish candlestick patterns or a breakout above recent consolidation highs. However, if the trendline support is breached, it could signal a potential shift in the trend.
Let me know your thoughts or if you see the setup differently!
$BEKE Inverse head and shouldersKE Holdings Inc. is a publicly traded Chinese real estate holding firm that offers a comprehensive online and offline platform for housing transactions and related services through its subsidiaries. It stands as the largest online real estate transaction platform in China.
Investors commonly refer to the entire operation as "Beike."
The company has garnered financial support from major players like Tencent, SoftBank Group, and Hillhouse Investment.
In August 2020, KE made its debut on the New York Stock Exchange (NYSE), successfully raising $2.12 billion during its initial public offering. On its first trading day, the stock soared by 87%, bringing the company's valuation to nearly $40 billion.
By May 2022, KE expanded its reach by becoming a dual-listed entity, adding its shares to the Hong Kong Stock Exchange.
KE operates two primary businesses: Lianjia and Beike. Lianjia functions as a real estate agency, while Beike serves as an online platform that connects customers with estate agents, including Lianjia. Lianjia is often likened to Redfin, whereas Beike is compared to Zillow.
The company is divided into four key business segments:
1. Existing home transaction services
2. New home transaction services
3. Home renovation and furnishing
4. Emerging and other services
$NTES NETEASE to benefit from Chinese stimulus.NetEase, Inc. is a prominent Chinese internet technology firm established by Ding Lei in June 1997. The company offers a diverse range of online services encompassing content, community engagement, communication, and commerce. It specializes in the development and operation of online games for both PC and mobile platforms, alongside advertising, email services, and e-commerce solutions within China. As one of the largest players in the global internet and video game industry, NetEase also manages several pig farms. Additionally, it features an on-demand music streaming service. Notable video game titles from NetEase include Fantasy Westward Journey, Tianxia III, Heroes of Tang Dynasty Zero, and Ghost II. From 2008 to 2023, the company was responsible for the Chinese versions of popular Blizzard Entertainment games, including World of Warcraft, StarCraft II, and Overwatch. In August 2023, NetEase unveiled a new American studio, spearheaded by veterans from Bethesda and BioWare.
ELI LILLY ahead of a 1D Golden Cross targeting $1225Last time we looked at Eli Lilly (LLY) 3 months ago (November 21 2024, see chart below), we've identified the bottom of its 5-year Channel Up and issued a strong long-term buy signal:
Now we are upgrading our Target as the price action turned out to be very similar to the 2nd half of 2020, at the end of which the company witnessed strong growth.
As you can see both 2020 and 2024 patterns have been correction phases in the form of Channel Downs. Even their 1D RSI sequences are similar. A 1D Death Cross paved the way for the bottom soon after and a 1D Golden Cross (Jan 11 2021) confirmed the start of a new phase of growth.
The price is now above the 1D MA200 (orange trend-line) and if it continues to replicate 2021, then we expect this to be a Bullish Leg that will target the 1.786 Fibonacci extension. Our long-term Target now goes from $1135 to $1225.
-------------------------------------------------------------------------------
** Please LIKE 👍, FOLLOW ✅, SHARE 🙌 and COMMENT ✍ if you enjoy this idea! Also share your ideas and charts in the comments section below! This is best way to keep it relevant, support us, keep the content here free and allow the idea to reach as many people as possible. **
-------------------------------------------------------------------------------
💸💸💸💸💸💸
👇 👇 👇 👇 👇 👇
US30 | Holding Support – Ready for the Next Leg Up?📊 US30 (Dow Jones) – Technical Analysis (4H Chart)
🔹 Market Outlook:
Price is trading within an ascending channel, indicating a bullish bias while above key support levels.
The pivot zone at 44,404 is acting as a critical level to maintain bullish momentum.
A break above 44,756 - 44,926 will confirm further upside potential.
🔥 Bullish Scenario:
✅ As long as price holds above 44,404 - 44,570 → Bullish trend remains intact!
📌 Targets:
📍 44,756 (first resistance)
📍 44,926 (next key resistance)
📍 45,099 - 45,323 (major resistance zone & ATH area)
⚠️ Bearish Scenario:
❌ A 4H close below 44,404 could trigger a deeper correction.
📌 Support Targets:
📍 44,260 (first support zone)
📍 43,910 (strong demand area)
📍 Below 43,763 = deeper pullback likely
🔑 Key Levels:
📍 Pivot Zone: 44,404 - 44,570
📍 Resistance: 44,756 | 44,926 | 45,099 - 45,323
📍 Support: 44,404 | 44,260 | 43,910
📌 Conclusion:
✅ Bullish momentum holds above 44,404, targeting 44,756+.
🚀 Break above 44,926 will open the door for a test of 45,099 - 45,323.
⚠️ Drop below 44,404 = possible correction to 44,260 - 43,910.
💬 Do you think we push to new highs or see a pullback first? Drop your thoughts! 👇🔥
S&P 500 (SPX500USD) | Breakout or Rejection? Key Levels to Watch📊 S&P 500 (SPX500USD) – Key Technical Outlook (4H Chart)
🔹 Price Action: The market is consolidating around the 6,107 - 6,122 resistance zone (ATH area). A decisive breakout or rejection from this zone will dictate the next move.
🔹 Bias: As long as the price holds above 6,031, the bullish momentum remains intact within the ascending channel.
🔥 Potential Bullish Scenario:
✅ A 4H close above 6,127 = Breakout confirmation 🚀
📌 Targets:
📍 6,168 (first resistance)
📍 6,224 - 6,279 (next key resistance zone)
⚠️ Potential Bearish Scenario:
❌ A 4H close below 6,098 could trigger a retracement 🔻
📌 Targets:
📍 6,077 (minor support)
📍 6,031 (major support & channel base)
📍 6,010 - 5,979 (next demand zone)
🔑 Key Levels:
📍 Pivot Point: 6,098
📌 Resistance: 6,127, 6,168, 6,224-6,279
📌 Support: 6,077, 6,031, 6,010
Conclusion:
📈 Bullish bias remains intact unless price breaks below 6,098 with confirmation.
🔥 Breakout above 6,127 = new bullish leg targeting fresh highs!
⚠️ Rejection from 6,122 - 6,127 may trigger a retracement to 6,031 - 6,010 before further upside.
💬 What’s your bias? Are we breaking ATH or pulling back? Drop your thoughts below! 👇
SPX Finally Pops - But Will It Stick?SPX Finally Pops – But Will It Stick? | SPX Market Analysis 14 Feb 2025
Well, pop the champagne, sound the victory bells, and maybe slap my thigh and call me Rodger—SPX has finally broken out! The only thing missing is a trumpet fanfare and maybe a ticker-tape parade.
But before we get too carried away, the real question remains—will this breakout hold strong or collapse into another Friday sell-off?
Let’s break it down…
SPX Deeper Dive Analysis:
🎉 The Market Has Moved – But Will It Last?
After days of tedious range-bound trading, SPX finally decided to pick a direction. But if history is anything to go by, we can’t get too comfortable just yet.
🔻 Friday Sell-Off Risk
If the last few weeks are anything to go by, we’ve seen:
A break higher, only for it to reverse sharply by Friday
A hard and fast flush that wipes out the week’s gains
A market that keeps traders on their toes
📉 Bear Trades Expire Today
My bearish positions are expiring
We never quite got the drop to range lows
A last-minute sell-off could help—but I won’t be holding my breath
🔄 What’s Next?
✅ Option 1: Look for a fresh swing trade entry today
✅ Option 2: Sit back, relax, and enjoy a long romantic weekend 😉
📌 Final Takeaway?
The range is finally broken, but we’ve been burned before by Friday sell-offs. Patience is key—there’s always another trade, but a long weekend is also tempting.
📢 Did you know? The biggest one-day stock market gain in history happened on March 24, 2020, when the Dow surged 2,113 points.
💡 The Lesson? Even record-breaking rallies can happen after massive crashes. Markets move in cycles—so while sell-offs seem endless, breakouts eventually happen… and vice versa.
ADTRAN (ADTN) AnalysisCompany Overview:
ADTRAN NASDAQ:ADTN is a leader in broadband access, fiber optics, and 5G technologies, providing high-speed connectivity solutions for service providers. The company is positioned to benefit from expanding fiber deployments and emerging defense and government contract opportunities.
Key Catalysts:
Enhanced Short-Term Unit (ESTU) Module ⚙️
ADTRAN’s new ESTU timing module is a game-changer for securing high-margin contracts in defense, space, and metrology. This innovation taps into a $700 million U.S. military communication market.
5G and Fiber Expansion 📶
As telecom operators accelerate fiber and 5G deployments, ADTRAN’s OSC-52v3 timing solution targets a $1.2 billion Total Addressable Market (TAM) through 2027.
Defense Contract Favorability 🛡️
Department of Defense (DoD) supply chain audits that prioritize domestic suppliers could further boost ADTRAN’s growth potential in the U.S. defense sector.
Sector Tailwinds 🌬️
The ongoing expansion of broadband infrastructure, driven by federal and private investment in fiber and high-speed networks, provides long-term tailwinds for ADTRAN’s core business.
Investment Outlook:
Bullish Case: We remain bullish on ADTN above the $9.00-$9.50 range, supported by product innovation, expanding defense market opportunities, and strong fiber/5G sector growth.
Upside Potential: Our price target is $16.00-$17.00, reflecting confidence in ADTRAN’s ability to leverage sector tailwinds and capitalize on defense and fiber deployment opportunities.
📢 ADTRAN—Advancing Connectivity with Fiber, 5G, and Defense Innovation. #Broadband #FiberOptics #ADTN
Stock Trading, a more 'calmer' way to tradeFind a trend and stay on trend, take profit when you can and when happy.
Nightly $SPY / $SPX Scenarios for 2.14.2025🔮
🌍 Market-Moving News:
Trump Signs Reciprocal Tariffs Executive Order: President Donald Trump has signed an executive order imposing reciprocal tariffs on countries with trade barriers against the U.S. The tariffs will not take effect immediately, which has been well-received by the markets.
Potential Ukraine Peace Talks: The U.S. is initiating discussions with Russia and Ukraine to potentially end the ongoing conflict. This development has led to a decrease in crude oil prices and could influence global markets.
📊 Key Data Releases:
📅 Friday, Feb 14:
🛍️ Retail Sales (8:30 AM ET):
Forecast: -0.1% MoM; Previous: +0.4% MoM.
🌐 U.S. Import and Export Price Indexes (8:30 AM ET):
Import Prices: Forecast: +0.5% MoM; Previous: +0.1% MoM.
Export Prices: Forecast: Data not available; Previous: +0.3% MoM
📌 #trading #stockmarket #SPY #SPX #daytrading #charting #trendtao
Tempus AI Possible Partner for the Stargate Project in the USAAnalysis of Possible Surge in Tempus AI Stock Due to Project Stargate
Introduction
Tempus AI, Inc. has emerged as a key player in the health technology space, leveraging data science and artificial intelligence (AI) to develop precision medicine solutions. The company's focus on oncology, cardiology, and mental health, combined with its strong data-driven approach, has positioned it as a leader in the emerging field of AI-enabled healthcare. A possible surge in Tempus AI’s stock price is now being speculated, due to its potential involvement in Project Stargate, a new initiative spearheaded by President Donald Trump. Project Stargate promises significant investments and infrastructure development in AI, which could catalyze a favorable growth trajectory for Tempus.
This analysis will explore the potential impact of Project Stargate on Tempus AI, considering both the direct and indirect benefits for the company. Additionally, the mention of prominent political figures like Nancy Pelosi purchasing Tempus stock adds an interesting layer to the speculative nature of this surge.
---
Project Stargate Overview
Project Stargate, as outlined by former President Donald Trump, aims to overhaul AI infrastructure in the U.S. The initiative seeks to foster partnerships between technology firms, including AI-focused companies like OpenAI, and businesses involved in critical infrastructure, such as data centers, power generation, and construction. The project’s goal is to drive advancements in AI technology, with a specific focus on enhancing U.S. competitiveness in this rapidly growing field.
The strategic involvement of multiple high-profile organizations and the federal government indicates that Project Stargate is likely to have wide-reaching economic and technological ramifications. Key elements of the project include:
-Infrastructure Investments: The construction and expansion of AI-driven data centers and related infrastructure.
- Public-Private Partnerships: Strong cooperation between private companies and government entities, facilitating new technologies and business models.
- Technological Advancements: AI solutions that push the boundaries of healthcare, cybersecurity, and national security.
As a result, companies involved in the development and deployment of AI technology, particularly those in healthcare and data analytics, are poised to benefit significantly.
---
Tempus AI’s Position in Project Stargate
Tempus AI operates at the intersection of healthcare and AI, which makes it an intriguing candidate to potentially benefit from Project Stargate. The company’s focus on precision medicine using AI-driven diagnostics aligns well with the ambitions of Project Stargate to expand AI infrastructure.
1. Synergies with Healthcare AI
Project Stargate is expected to fuel demand for AI infrastructure and innovations, particularly in sectors like healthcare. Tempus, which specializes in oncology, cardiology, and depression diagnostics, stands to benefit from both the increased focus on AI-powered healthcare solutions and the additional resources available through government-private sector partnerships.
Given Tempus’s reliance on large-scale data analysis to build its precision medicine solutions, any acceleration in AI infrastructure could lower operational costs for Tempus while improving the capabilities of its platform. Enhanced AI infrastructure would likely lead to faster data processing, increased diagnostic accuracy, and the potential for more personalized treatments.
2. Expansion of Partnerships and Funding
The potential for public-private partnerships, which Project Stargate promotes, could help Tempus secure additional government contracts or private sector collaborations. This influx of capital and resources could enable the company to scale its technology faster and expand into new medical areas beyond its current focus on cancer, cardiology, and mental health.
3. Alignment with National AI Strategy
With AI being a major focus of Project Stargate, Tempus may find itself well-positioned within the broader national AI strategy. If the company becomes a key partner in helping build AI solutions for healthcare or other sectors, it could solidify its reputation as an industry leader, driving up stock demand and valuation.
---
Nancy Pelosi’s Stock Purchase: A Political Angle
The mention of Nancy Pelosi, a prominent U.S. politician, purchasing Tempus AI stock adds a speculative element to the situation. Pelosi’s involvement in the stock could be seen as a potential signal of confidence in Tempus AI’s future performance. Politicians often make investment decisions based on inside knowledge of forthcoming legislation, partnerships, or government contracts.
Though speculation about Pelosi’s investment could generate increased media attention, it should be approached with caution. However, if Pelosi’s investment is tied to a potential announcement of government support or strategic alignment between Tempus and Project Stargate, it could amplify investor confidence and trigger a buying frenzy.
---
Potential Catalysts for Stock Surge
Several factors could drive a surge in Tempus AI’s stock price if Project Stargate moves forward:
-1. Government Contracts and Funding: If Tempus is awarded government contracts under Project Stargate, particularly related to AI infrastructure or healthcare solutions, the company could see a significant increase in revenue and market capitalization.
-2. Partnerships with Major Players: Any announcement of Tempus AI partnering with companies like OpenAI or other stakeholders in Project Stargate would likely signal strong growth potential and increase investor interest.
-3. ncreased Demand for AI Healthcare Solutions**: As the U.S. government prioritizes AI advancements, healthcare applications could see substantial growth. Tempus could be a key beneficiary of this shift, leading to a surge in its stock price as market expectations align with actual developments.
-4. Political Endorsement: If high-profile political figures continue to signal support for Tempus AI, either through public statements or stock purchases, it could bolster public perception and attract institutional investors.
---
Risks and Considerations
While there is substantial upside potential for Tempus AI, there are also risks to consider:
- Dependence on Project Stargate’s Success: Tempus’s growth will be closely tied to the success of Project Stargate and its integration into the broader national AI ecosystem. If the project faces delays or fails to meet expectations, it could have negative implications for companies like Tempus.
- Regulatory Risks: The healthcare industry is heavily regulated, and any change in regulatory policies could impact Tempus’s ability to grow at the expected pace. While AI infrastructure investment may mitigate some challenges, government policies could still create obstacles.
- Market Volatility: The stock market, particularly tech and healthcare stocks, is inherently volatile. Any unforeseen global events or shifts in economic conditions could negatively affect Tempus’s valuation, regardless of Project Stargate.
---
Conclusion
Tempus AI stands at an exciting intersection of AI technology and healthcare, which could see its stock price surge due to its involvement in Project Stargate. The initiative’s focus on building AI infrastructure and fostering partnerships could provide Tempus with opportunities for rapid growth, enhanced funding, and access to cutting-edge technology.
The involvement of high-profile political figures such as Nancy Pelosi adds an additional layer of speculation, with the potential for both public perception and market sentiment to play a significant role in the stock’s trajectory. However, investors should consider the risks associated with regulatory changes, market volatility, and the uncertain success of Project Stargate itself.
Ultimately, if Tempus AI is able to capitalize on these emerging opportunities, it could see a substantial boost in both market visibility and stock price in the near future.
For any questions or remarks kindly react here under the comments
Greetings,
Zila
Is Liquidity Zones The Hidden Battleground of Smart Money In every market move, liquidity zones are the battlefields between buyers and sellers. Understanding these zones is crucial for spotting reversals and breakouts before they happen.
What Are Liquidity Zones?
High Liquidity Areas, Where large orders are placed, typically around key support/resistance or round numbers.
Low Liquidity Areas. Where price moves quickly due to fewer orders, often creating price imbalances.
Why Liquidity Matters
Smart money (institutions) seeks liquidity to execute large orders without massive slippage. Their footprints appear as wicks, sudden volume spikes, or rapid price reversals.
Spotting Liquidity Traps
False Breakouts, Price pierces a key level, triggers stop losses, and reverses quickly.
Stop Hunts, Sudden price spikes beyond a key level, only to return inside the range.
rading Strategy Example
1. Use volume profile or heat maps to spot high-interest price areas.
2. Wait for Reaction, Enter only after confirmation (e.g., a sharp wick or order flow shift).
3.Risk Management, Place stops beyond liquidity zones to avoid getting trapped.
Master liquidity zones, and you'll start seeing the market through the eyes of institutional players.
Broadcom - This Chart Is Just Splendid!Broadcom ( NASDAQ:AVGO ) is starting the rejection:
Click chart above to see the detailed analysis👆🏻
For the past decade, Broadcom has been trading in an obvious rising channel formation, perfectly rejecting the upper resistance as well as the lower support trendline. With the recent weakness, Broadcom is now preparing for a clean rejection away from the major reversal area.
Levels to watch: $250, $150
Keep your long term vision,
Philip (BasicTrading)
$TLSA Poised For An 85% Surge Amidst Alzheimer’s Drug BoomTiziana Life Sciences Ltd (NASDAQ: NASDAQ:TLSA ), a stock that has been under the radar, is now showing strong signals of a potential breakout. With a falling wedge pattern and a bullish RSI reading, coupled with the growing interest in Alzheimer’s drug development, NASDAQ:TLSA is positioning itself as a stock to watch in 2025.
Technical Analysis
As of the time of writing, (NASDAQ: NASDAQ:TLSA ) shares are down 5.52%, but this dip is likely a temporary setback. The stock’s Relative Strength Index (RSI) stands at 52.77, which, despite the recent decline, suggests that bullish momentum is building. The RSI is neither overbought nor oversold, indicating a healthy consolidation phase before a potential upward move.
The most Intriguing technical indicator is the falling wedge pattern that has formed since January 23. This pattern is typically a bullish reversal signal, especially after a prolonged downtrend. The falling wedge is characterized by converging trendlines that slope downward, with the price making lower highs and lower lows. As the pattern nears its apex, the likelihood of a breakout increases.
For NASDAQ:TLSA , the immediate support lies at the 78.6% Fibonacci retracement level. A pullback to this zone could serve as an excellent buying opportunity for traders, as it aligns with recent resistance-turned-support levels. On the upside, the 38.2% Fibonacci retracement level is acting as a pivot point. A breakout above this level could ignite a bullish rally, potentially propelling the stock toward an 85% surge.
Alzheimer’s Drugs – The Next Big Market Opportunity
While the technical setup is compelling, the story behind NASDAQ:TLSA is equally intriguing. The Alzheimer’s drug market is emerging as the next big opportunity, drawing parallels to the obesity drug boom led by companies like Eli Lilly and Novo Nordisk. With an estimated market value of $13 billion by 2030, according to Bloomberg Intelligence, the race to develop effective Alzheimer’s treatments is heating up.
Companies like Biogen Inc., Eli Lilly & Co., Novo Nordisk, and Roche AG are investing billions into Alzheimer’s research. Recent developments have shown promise, with two new drugs—Leqembi (developed by Biogen and Eisai) and Kisunla (by Eli Lilly)—already approved in the U.S. These drugs target amyloid plaques in the brain, slowing the progression of the disease in its early stages. However, they are not without challenges, as side effects like brain bleeding and swelling have been reported.
For (NASDAQ: NASDAQ:TLSA ) stock, this presents a unique opportunity. If the company is involved in Alzheimer’s research or has partnerships with major pharmaceutical players, it could benefit significantly from the growing interest in this sector. Even if NASDAQ:TLSA is not directly involved, the overall bullish sentiment in the healthcare and biotech sectors could provide a tailwind for the stock.
Additionally, any positive developments in Alzheimer’s drug trials or approvals could act as a catalyst for NASDAQ:TLSA , driving the stock higher. As Gregoire Biollaz, senior investment manager at Pictet Asset Management, noted, “It could be a year where we also see a bit more clarity in terms of traction for the drugs that are approved so far.”
Conclusion
NASDAQ: NASDAQ:TLSA is at a critical juncture, with both technical and fundamental indicators pointing to a potential surge. The falling wedge pattern suggest that the stock is building momentum, while the growing interest in Alzheimer’s drugs provides a strong fundamental catalyst. For investors seeking the next big opportunity, NASDAQ:TLSA could be the stock to watch in 2025.
As always, investors should conduct their own due diligence and consider their risk tolerance before making any investment decisions. However, with an 85% surge on the horizon, NASDAQ:TLSA is undoubtedly a stock worth keeping on your radar.
TSLA - Filling the gap and then upside?The stock is trading around $337, showing significant volatility after a sharp decline from recent highs near $480. There's a notable gap in the price action around the $260-280 region that hasn't been filled.
The overall price action has formed a series of lower highs since the recent peak.
The current technical structure suggests potential weakness in the near term. The unfilled gap around $260-280 could act as a magnetic price level. Historical price action shows that gaps tend to get filled eventually, supporting the likelihood of a move down to this region.
NVIDIA: last accumulation before $260 rally.NVIDIA is neutral on its 1D technical outlook (RSI = 49.723, MACD = -1.780, ADX = 32.427) as the price is accumulating in preparation for the 2025 rally. We are on a 1D MA50-100 squeeze that looks very much like November 6th 2023. The 1D RSI patterns among those two Bull Flags are also identical and what followed this squeeze was a +150% rally from the last bottom. The trade is long (TP = 260.00) aiming for a full +150% extension.
See how our prior idea has worked out:
## If you like our free content follow our profile to get more daily ideas. ##
## Comments and likes are greatly appreciated. ##
FRESHWORKS ($FRSH): DRIVING AI-POWERED GROWTH IN SaaSFRESHWORKS ( NASDAQ:FRSH ): DRIVING AI-POWERED GROWTH IN SaaS
1/7
Revenue Growth: Freshworks just posted $194.6M in Q4 2024 (+22% YoY), with full-year revenue hitting $ 720M (+21% YoY)! ⚡️
Growth is fueled by new customer wins and the rising AI demand in customer service, sales, and IT solutions.
2/7 – EARNINGS BEAT
• Non-GAAP EPS: $0.14 (beat by $0.04) 💰
• Operating profit for FY2024 doubled to $ 99M from $ 44.5M in 2023 🔥
• FY2025 guidance: Revenue $ 809M–$ 821M (12–14% YoY growth) 🚀
3/7 – CASH FLOW & PROFITABILITY
• Free Cash Flow margin at 21% in Q4—showing major profitability strides 💸
• Shifting from less profitable past to a more robust, scalable business model 🏆
4/7 – SECTOR SNAPSHOT
• Competes with Salesforce, HubSpot, Zendesk in the SaaS arena 🌐
• Enterprise Value to Revenue ratio is on the lower end—could be undervalued given its growth 📈
• Mid-market & SMB focus → niche advantage vs. pricier enterprise solutions
5/7 – RISK FACTORS
• Market Competition: Big fish (Salesforce) + fresh entrants (Zendesk) 🏦
• Customer Acquisition: High marketing costs, must maintain ROI 🤝
• Economic Sensitivity: Downturn = possible budget cuts on software 💼
• Tech Shifts: Rapid AI innovation—no resting on laurels! 🤖
6/7 – SWOT HIGHLIGHTS
Strengths:
• Strong AI-driven revenue growth
• Wide product portfolio (sales, IT, support, etc.)
• Growing customer base & retention ✅
Weaknesses:
• Less profitable historically (though improving)
• Revenue heavily reliant on core products 😬
Opportunities:
• Expand into untapped global markets
• Double down on AI for new revenue streams 🌍
Threats:
• Market saturation & intense competition 🏁
• Data privacy regs could disrupt operations ⚖️
7/7 Freshworks: undervalued gem or just another SaaS player?
1️⃣ Bullish—AI + mid-market niche = unstoppable! 🏅
2️⃣ Neutral—Need more proof of profitability 🤔
3️⃣ Bearish—Competition & economy hold it back 🐻
Vote below! 🗳️👇
